Osteoporosis Therapy in Postmenopausal Women With High Risk of Fracture

被引：25

作者：

Cappola, Anne R. ^{[1
]}

Shoback, Dolores M. ^{[2
]}

机构：

[1] Univ Penn, Perelman Sch Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA

[2] Univ Calif San Francisco, San Francisco Dept Vet Affairs Med Ctr, Endocrine Res Unit, San Francisco, CA 94143 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 316卷 / 07期

关键词：

D O I：

10.1001/jama.2016.11032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：715 / 716

页数：2

共 50 条

[1] Lifetime Risk of Fracture Among Postmenopausal Women With Osteoporosis And at High Risk of Fracture
Brunetti, Vanessa C.
Chien, Hsu-Chih
McDermott, Michele
Lin, Tzu-Chieh
Kim, Min
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 573 - 574
[2] LIFETIME RISK OF FRACTURE AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND AT HIGH RISK OF FRACTURE
Brunetti, V. C.
Chien, H-C
Mcdermott, M.
Lin, T-C
Kim, M.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S582 - S583
[3] Osteoporosis in postmenopausal women - Therapy options across a wide range of risk for fracture
Miller, RG
GERIATRICS, 2006, 61 (01) : 24 - 30
[4] Adherence with drug therapy and risk of fracture among women with postmenopausal osteoporosis.
Weycker, D
Macarios, D
Oster, G
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S383 - S383
[5] Determinants of imminent fracture risk in postmenopausal women with osteoporosis
R. L. Barron
G. Oster
A. Grauer
D. B. Crittenden
D. Weycker
Osteoporosis International, 2020, 31 : 2103 - 2111
[6] Determinants of imminent fracture risk in postmenopausal women with osteoporosis
Barron, R. L.
Oster, G.
Grauer, A.
Crittenden, D. B.
Weycker, D.
OSTEOPOROSIS INTERNATIONAL, 2020, 31 (11) : 2103 - 2111
[7] Bazedoxifene reduces the risk of fracture in women with postmenopausal osteoporosis
Nature Clinical Practice Rheumatology, 2008, 4 (11): : 566 - 566
[8] Clinical evaluation of osteoporosis and fracture risk in postmenopausal women
McClung B.
Clinical Reviews in Bone and Mineral Metabolism, 2006, 4 (1): : 15 - 23
[9] Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
Api, M
JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (08) : 1480 - 1481
[10] OSTEOPOROSIS TREATMENT RANKING IN POSTMENOPAUSAL WOMEN AT HIGH RISK OF FRACTURE IN BRAZIL: MCDA APPROACH
Mensor, L.
Rosim, M. P.
Marchesan, T.
Amaral, L. Murta
VALUE IN HEALTH, 2023, 26 (06) : S148 - S148

← 1 2 3 4 5 →